Contents of this document
- One-time expenses associated with relocating the Tokyo head office¥-62 million
- Impact of the profitability of 2 individual projects¥-75 million
- Other factors affecting the change, including growth investment in the brand business¥34 million
- Quarterly net profit¥155 millionFactorsImpairment loss on fixed assets
- Establishment of a specialist generative AI team
- Pilot use of generative AI in selected projects
- Rollout across all business divisions in fiscal 2027
- Launch of talent development and training investment, a consulting structure and other initiatives in the brand business
- Execution of the share buyback
- ROE16.6 %
- DX & SI businessNet SalesCurrent Q1 ¥4,850 million / Prior Q1 ¥4,588 million / Change ¥262 millionOperating profitCurrent Q1 ¥820 million / Prior Q1 ¥821 million / Change ¥-1 million
- Package BusinessNet SalesCurrent Q1 ¥1,444 million / Prior Q1 ¥1,397 million / Change ¥46 millionOperating profitCurrent Q1 ¥280 million / Prior Q1 ¥373 million / Change ¥-92 million
- Healthcare Big Data BusinessNet SalesCurrent Q1 ¥650 million / Prior Q1 ¥566 million / Change ¥84 millionOperating profitCurrent Q1 ¥31 million / Prior Q1 ¥52 million / Change ¥-20 million
- Global BusinessNet SalesCurrent Q1 ¥491 million / Prior Q1 ¥487 million / Change ¥3 millionOperating profitCurrent Q1 ¥-48 million / Prior Q1 ¥-89 million / Change ¥40 million
- Corporate ExpensesOperating profitCurrent Q1 ¥-693 million / Prior Q1 ¥-664 million / Change ¥-28 million
- ROETarget value20% or higherActual value16.6% (fiscal year ended March 2026)
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥7,437 million (YoY +5.6%) |
| Operating profit | ¥390 million (YoY -21.0%) |
| Ordinary income | ¥402 million (YoY -21.0%) |
| Net income | ¥113 million (YoY -64.8%) |
| Results for the three months of the current quarter | Revenue of ¥7,437 million, operating income of ¥390 million, ordinary income of ¥402 million, and quarterly net income of ¥113 million. First-quarter revenue and operating income are presented by segment. |
| Full-year earnings forecast | Net Sales ¥34,300 million / Operating profit ¥4,150 million / Ordinary income ¥4,200 million / Net income for the current fiscal year ¥2,950 million |
| Progress against full-year forecast | First-quarter progress toward the full-year ordinary income forecast was 9.6%. The average for the previous 4 fiscal years was 9.7%. Progress rates for other line items were Not disclosed. |
| Self-assessment against the plan | In line with plan |
| Segment results | Segment DX & SI business / Net Sales Current Q1 ¥4,850 million / Prior Q1 ¥4,588 million / Change ¥262 million / Operating profit Current Q1 ¥820 million / Prior Q1 ¥821 million / Change ¥-1 million, Segment Package Business / Net Sales Current Q1 ¥1,444 million / Prior Q1 ¥1,397 million / Change ¥46 million / Operating profit Current Q1 ¥280 million / Prior Q1 ¥373 million / Change ¥-92 million, Segment Healthcare Big Data Business / Net Sales Current Q1 ¥650 million / Prior Q1 ¥566 million / Change ¥84 million / Operating profit Current Q1 ¥31 million / Prior Q1 ¥52 million / Change ¥-20 million, Segment Global Business / Net Sales Current Q1 ¥491 million / Prior Q1 ¥487 million / Change ¥3 million / Operating profit Current Q1 ¥-48 million / Prior Q1 ¥-89 million / Change ¥40 million, Segment Corporate Expenses / Net Sales Not disclosed / Operating profit Current Q1 ¥-693 million / Prior Q1 ¥-664 million / Change ¥-28 million |
| Breakdown of Factors Affecting the Change | Factors One-time expenses associated with relocating the Tokyo head office / Amount ¥-62 million, Factors Impact of the profitability of 2 individual projects / Amount ¥-75 million, Factors Other factors affecting the change, including growth investment in the brand business / Amount ¥34 million, Factors Impairment loss on fixed assets / Amount ¥155 million / Subject Quarterly net profit |
| Key KPIs | Indicator name ROE / Value 16.6 % / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | Earnings are weighted toward the second half. Specific numerical assumptions for foreign exchange rates, raw material prices, interest rates, volumes and other factors were Not disclosed. |
| Medium-term management plan targets | A final target of ROE of 20% or more, with the aim of improving from 16.6% in the fiscal year ended March 2026. Targets also include a dividend payout ratio of 50% and a total shareholder return ratio of 50% or more. |
| Financial targets | Indicator ROE / Target value 20% or higher / Actual value 16.6% (fiscal year ended March 2026) |
| Annual Dividend | Annual Dividend Forecast ¥50 per share / Interim and Year-End Breakdown Not disclosed |
| Payout ratio | 50% |
| Acquisition of treasury shares | Total number of shares acquired Up to 2,000,000 shares (8.06% of total shares issued) / Total acquisition cost Up to ¥2.5 billion / Period 1 July 2026 to 25 June 2027 / Policy following the acquisition All acquired shares are scheduled to be cancelled, except for shares allocated to employee RS awards and other purposes. |
| New initiatives | Establishment of a specialist generative AI team, Pilot use of generative AI in selected projects, Rollout across all business divisions in fiscal 2027, Launch of talent development and training investment, a consulting structure and other initiatives in the brand business, Execution of the share buyback |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The decline in operating income was attributable to a one-time ¥62 million expense associated with relocating the Tokyo head office, a ¥75 million impact from the profitability of 2 individual projects, and other factors including growth investment in the brand business. The decline in net income was due to a ¥155 million impairment loss on fixed assets following the decision to sell the employee dormitory.